Cargando…

Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities

BACKGROUND: Healthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia. METHODS: This study is a cross-sectional study focused on e...

Descripción completa

Detalles Bibliográficos
Autores principales: Malagón-Rojas, Jeadran Nevardo, Mercado-Reyes, Marcela, Toloza-Pérez, Yezith G, Parra Barrera, Eliana L, Palma, Marien, Muñoz, Esperanza, López, Ronald, Almentero, Julia, Rubio, Vivian V, Ibáñez, Edgar, Téllez, Eliana, Delgado-Murcia, Lucy G, Jimenez, Claudia P, Viasus-Pérez, Diego, Galindo, Marisol, Lagos, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577941/
https://www.ncbi.nlm.nih.gov/pubmed/34740981
http://dx.doi.org/10.1136/oemed-2021-107487
_version_ 1784596167672201216
author Malagón-Rojas, Jeadran Nevardo
Mercado-Reyes, Marcela
Toloza-Pérez, Yezith G
Parra Barrera, Eliana L
Palma, Marien
Muñoz, Esperanza
López, Ronald
Almentero, Julia
Rubio, Vivian V
Ibáñez, Edgar
Téllez, Eliana
Delgado-Murcia, Lucy G
Jimenez, Claudia P
Viasus-Pérez, Diego
Galindo, Marisol
Lagos, Luisa
author_facet Malagón-Rojas, Jeadran Nevardo
Mercado-Reyes, Marcela
Toloza-Pérez, Yezith G
Parra Barrera, Eliana L
Palma, Marien
Muñoz, Esperanza
López, Ronald
Almentero, Julia
Rubio, Vivian V
Ibáñez, Edgar
Téllez, Eliana
Delgado-Murcia, Lucy G
Jimenez, Claudia P
Viasus-Pérez, Diego
Galindo, Marisol
Lagos, Luisa
author_sort Malagón-Rojas, Jeadran Nevardo
collection PubMed
description BACKGROUND: Healthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia. METHODS: This study is a cross-sectional study focused on estimating the seroprevalence of SARS-CoV-2 antibodies in healthcare workers from 65 hospitals in 10 cities in Colombia during the second semester of 2020. The seroprevalence was determined using an automated immunoassay (Abbott SARS-CoV-2 CLIA IgG). The study included a survey to establish the sociodemographic variables and the risk of infection. A multivariate model was used to evaluate the association between the results of seroprevalence and risk factors. RESULTS: The global seroprevalence of antibodies against SARS-CoV-2 was 35% (95% Bayesian CI 33% to 37%). All the personnel reported the use of protective equipment. General services personnel and nurses presented the highest ratios of seroprevalence among the healthcare workers. Low socioeconomic strata have shown a strong association with seropositivity. CONCLUSION: This study estimates the prevalence of SARS-CoV-2 infection among healthcare workers. Even though all the personnel reported the use of protective equipment, the seroprevalence in the general services personnel and nurses was high. Also, a significant difference by cities was observed.
format Online
Article
Text
id pubmed-8577941
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85779412021-11-10 Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities Malagón-Rojas, Jeadran Nevardo Mercado-Reyes, Marcela Toloza-Pérez, Yezith G Parra Barrera, Eliana L Palma, Marien Muñoz, Esperanza López, Ronald Almentero, Julia Rubio, Vivian V Ibáñez, Edgar Téllez, Eliana Delgado-Murcia, Lucy G Jimenez, Claudia P Viasus-Pérez, Diego Galindo, Marisol Lagos, Luisa Occup Environ Med Workplace BACKGROUND: Healthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia. METHODS: This study is a cross-sectional study focused on estimating the seroprevalence of SARS-CoV-2 antibodies in healthcare workers from 65 hospitals in 10 cities in Colombia during the second semester of 2020. The seroprevalence was determined using an automated immunoassay (Abbott SARS-CoV-2 CLIA IgG). The study included a survey to establish the sociodemographic variables and the risk of infection. A multivariate model was used to evaluate the association between the results of seroprevalence and risk factors. RESULTS: The global seroprevalence of antibodies against SARS-CoV-2 was 35% (95% Bayesian CI 33% to 37%). All the personnel reported the use of protective equipment. General services personnel and nurses presented the highest ratios of seroprevalence among the healthcare workers. Low socioeconomic strata have shown a strong association with seropositivity. CONCLUSION: This study estimates the prevalence of SARS-CoV-2 infection among healthcare workers. Even though all the personnel reported the use of protective equipment, the seroprevalence in the general services personnel and nurses was high. Also, a significant difference by cities was observed. BMJ Publishing Group 2022-06 2021-11-05 /pmc/articles/PMC8577941/ /pubmed/34740981 http://dx.doi.org/10.1136/oemed-2021-107487 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Workplace
Malagón-Rojas, Jeadran Nevardo
Mercado-Reyes, Marcela
Toloza-Pérez, Yezith G
Parra Barrera, Eliana L
Palma, Marien
Muñoz, Esperanza
López, Ronald
Almentero, Julia
Rubio, Vivian V
Ibáñez, Edgar
Téllez, Eliana
Delgado-Murcia, Lucy G
Jimenez, Claudia P
Viasus-Pérez, Diego
Galindo, Marisol
Lagos, Luisa
Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
title Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
title_full Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
title_fullStr Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
title_full_unstemmed Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
title_short Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
title_sort seroprevalence of the sars-cov-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 colombian cities
topic Workplace
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577941/
https://www.ncbi.nlm.nih.gov/pubmed/34740981
http://dx.doi.org/10.1136/oemed-2021-107487
work_keys_str_mv AT malagonrojasjeadrannevardo seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT mercadoreyesmarcela seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT tolozaperezyezithg seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT parrabarreraelianal seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT palmamarien seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT munozesperanza seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT lopezronald seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT almenterojulia seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT rubiovivianv seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT ibanezedgar seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT tellezeliana seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT delgadomurcialucyg seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT jimenezclaudiap seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT viasusperezdiego seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT galindomarisol seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT lagosluisa seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities
AT seroprevalenceofthesarscov2antibodyinhealthcareworkersamulticentrecrosssectionalstudyin10colombiancities